Area of research
Oncology · Economics and Econometrics
Research interest
Research interests include Medicine, Breast cancer, Doxorubicin, Estrogen receptor, Oncology, and Estrogen.
Pegylated liposomal doxorubicin + cyclophosphamide followed by taxane as adjuvant therapy for early-stage breast cancer: a randomized controlled trial
Contemporaneous symptom networks and correlates during endocrine therapy among breast cancer patients: A network analysis
Cardiac safety and efficacy for patients with early-stage breast cancer treated with pegylated liposomal doxorubicin (PLD) or doxorubicin.
Concurrent neoadjuvant chemotherapy and estrogen deprivation in patients with estrogen receptor–positive, human epidermal growth factor receptor 2–negative breast cancer (CBCSG‐036): A randomized, controlled, multicenter trial